Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris
- PMID: 37146158
- DOI: 10.1093/ced/llad173
Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris
Conflict of interest statement
Conflicts of interest: the authors declare they have no conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
